JLS Pharma

La Bruyère ·KBO/BCE: BE 0771.655.091

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	06-10-2025	67 d late	2025-00530929
31-12-2023	31-07-2024	11-07-2024	20 d early	2024-00233913
31-12-2022	31-07-2023	06-07-2023	25 d early	2023-00207421

Metric	This company	Sector median	Position in the sector
Solvency	44.8%	17.3%	better than 78% of 866 sector peers
Net result	€7k	€14k	better than 43% of 867 sector peers
Equity	€98k	€100k	better than 50% of 868 sector peers
Gross operating margin	€200k	€213k	better than 48% of 794 sector peers
Staff costs	€189k	€219k	higher than 46% of 715 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€218k
Fixed assets	21/28	€6k
Formation expenses	20	€0
Intangible fixed assets	21	€6k
Tangible fixed assets	22/27	€66
Current assets	29/58	€212k
Stocks & contracts in progress	3	€70k
Amounts receivable within one year	40/41	€54k
Cash & bank	54/58	€84k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€218k
Equity	10/15	€98k
Contributions / capital	10/11	€25k
Reserves	13	€73k
Amounts payable	17/49	€120k
Amounts payable after one year	17	€29k
Amounts payable within one year	42/48	€92k
Trade debts payable within one year	44	€65k
Income statement
Gross operating margin	9900	€200k
Operating result	9901	€10k
Financial income	75	€78
Financial charges	65	€667
Result before taxes	9903	€9k
Income taxes	67/77	€2k
Net result for the period	9904	€7k
Result to be appropriated	9905	€7k

Summary

NACE primary	Detailhandel in farmaceutische producten(47730)
Legal form	Private limited company(610)
Incorporation	23-07-2021
Status	Active
Postal code	5081